Stay updated on Secukinumab in Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.

Latest updates to the Secukinumab in Psoriatic Arthritis: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study record for the FUTURE 4 secukinumab trial is displayed instead of an access-denied error, with details on the completed study and its reported outcomes.SummaryDifference79%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide banner announces an NIH website transition and says both “Artificial Intelligence” and “Super Intelligence” may appear in NIH content during the transition.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study details with a basic error screen to indicate restricted access.SummaryDifference18%

Stay in the know with updates to Secukinumab in Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.